{"TopicDetails": {"type": 0, "ccm2Id": 46982451, "cftId": 0, "identifier": "EU4H-2024-PJ-02-1", "title": "Call for Proposal to support integration of cancer images into the federated pan-European infrastructure to foster screening programmes - CR-g-24-37", "publicationDateLong": 1718668800000, "callIdentifier": "EU4H-2024-PJ-02", "callTitle": "EU4H Action Grants 2024", "callccm2Id": 46908104, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43332642, "abbreviation": "EU4H", "description": "EU4 Health Programme (EU4H)"}, "programmeDivision": [{"id": 44176644, "abbreviation": "Supporting", "description": "Supporting integrated and coordinated work between Member States"}], "topicMGAs": [], "sme": false, "actions": [{"status": {"id": 31094502, "abbreviation": "Open", "description": "Open"}, "types": [{"typeOfAction": "EU4H-PJG EU4H Project Grants", "typeOfMGA": [{"id": 43326018, "abbreviation": "EU4H-AG", "description": "EU4H Action Grant Budget-Based"}]}], "plannedOpeningDate": "18 June 2024", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["10 October 2024"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3543022": [{"action": "EU4H-2024-PJ-02-4 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 5000000}, "budgetTopicActionMap": {}}], "3543024": [{"action": "EU4H-2024-PJ-02-3 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 7400000}, "budgetTopicActionMap": {}}], "3543026": [{"action": "EU4H-2024-PJ-02-1 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 8000000}, "budgetTopicActionMap": {}}], "3543028": [{"action": "EU4H-2024-PJ-02-2 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "18 June 2024", "deadlineModel": "single-stage", "deadlineDates": ["10 October 2024"], "budgetYearMap": {"2024": 5000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2024"]}, "description": "<SPAN class=\"topicdescriptionkind\">Objective</SPAN>:<p>The action will provide enabling support for cancer imaging data providers, to contribute to and benefit from the European Cancer Imaging Initiative.</p><p>The action will improve readiness of national, regional or local imaging data repositories to connect and make available their data via the Cancer Image Europe infrastructure established under the DIGITAL programme (EUCAIM project<sup><a target=_self href=#fn1 id=r1>[1]</a></sup>) and to use this infrastructure for data enrichment and insights by accessing the nodes, tools and methodologies offered by EUCAIM.</p><p>This action is relevant for the proposed European Health Data Space. In order to contribute to the planned EHDS, this action will seek alignment with the relevant EHDS infrastructures (MyHealth@EU and HealthData@EU). Where applicable, it will link cancer imaging databases with the relevant bodies and infrastructures in the proposed EHDS, particularly health data access bodies and HealthData@EU.</p><p>This action will also explore ways to leverage on the EHDS interoperability specifications for the European Electronic Health Record exchange Format, including relevant eHealth Network guidelines, as well as minimum specifications for datasets to be used for research and innovation.</p><p>This action will support the Europe\u2019s Beating Cancer Plan objective to ensure high standards in cancer care and implements the EU4Health Programme\u2019s general objective of improving and fostering health in the Union to reduce the burden of communicable and non-communicable diseases (Article 3, point (a), of Regulation (EU) 2021/522) through the specific objectives defined in Article 4, points (a) and (g), of Regulation (EU) 2021/522.</p><p>This action will also support the implementation of the proposed EHDS Regulation and implement the EU4Health Programme\u2019s general objective of strengthening health systems (Article 3, point (d) of Regulation (EU) 2021/522) through the specific objective defined in Article 4, point (f), of Regulation (EU) 2021/522.</p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>This action contributes to the implementation of the Europe\u2019s Beating Cancer Plan.</p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>The action will support hospitals and other imaging repositories, for example those involved in conducting cancer screening, in creating enabling conditions for becoming a node in the European federated infrastructure of cancer imaging data. Short-term improvements include strengthening the collaboration between national and regional screening programmes for breast, lung and prostate cancers, with the European Cancer Imaging Infrastructure in particular regarding the management of the screening data and opportunistic screening (as opposed to organised, population-based screening programmes) and with the relevant infrastructures of the proposed European Health Data Space, such as HealthData@EU. The project beneficiaries are expected to represent a wide range of relevant stakeholders such as researchers, NGOs, experts, Member States institutions and industry.</p><p>In the mid-term, this action is expected to increase the geographical reach of the European Cancer Imaging Initiative. It will also contribute to the alignment of the European Cancer Imaging Infrastructure with the proposed EHDS infrastructures and processes.</p><p>Close collaboration of projects participants is expected with the European Cancer Imaging Initiative, in particular the EUCAIM project, and with relevant stakeholders involved in the implementation of the proposed EHDS regulatory framework, such as the TEHDAS 2 Joint Action, QUANTUM and the HealthData@EU pilot project<sup><a target=_self href=#fn2 id=r2>[2]</a></sup>. Links should be established with EU4Health actions on screening, Comprehensive Cancer Centres in Member States and other relevant actions under the Europe\u2019s Beating Cancer Plan and Cancer Mission, as well as with other relevant actions concerning the proposed EHDS. The action shall contribute to other relevant actions under the Europe\u2019s Beating Cancer Plan and the Cancer Mission.</p>\n<p id=fn1><a  target=_self href=#r1>[1]</a><a href=\"https://cancerimage.eu/\">https://cancerimage.eu/</a></p><p id=fn2><a  target=_self href=#r2>[2]</a><a href=\"https://ehds2pilot.eu/results/\">https://ehds2pilot.eu/results/</a></p>", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Conditions<br />\r\n<br type=\"_moz\" />\r\n</span></b></p>\r\n<p><b><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:&#10;text1;mso-themetint:191;mso-ansi-language:EN-US\">1.&nbsp;</span></b><b><span lang=\"EN-US\">Admissibility conditions: </span></b><span lang=\"EN-US\">described in section 5 of the call document</span>&nbsp;</p>\n<p><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\">&nbsp;described in Part B of the Application Form available in the Submission System</span></p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b><span lang=\"EN-US\">described in section 6 of of the call document</span></p>\n<p><b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in section 6 of the call document</span></p>\n<p><b>4. Financial and operational capacity and exclusion:&nbsp;</b>described in&nbsp;<span lang=\"EN-US\">section 7 of the call document</span></p>\n<p><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Award criteria, scoring and thresholds:</span></b><span lang=\"EN-US\">&nbsp;described in section 9 of the call document</span></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Submission and evaluation processes</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\">&nbsp;described&nbsp;<span style=\"color: rgb(64, 64, 64);\">section 8 of the call document and the</span>&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Online Manual</span></a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Indicative timeline for evaluation and grant agreement:&nbsp;</span></b><span lang=\"EN-US\">described in section 4 of the call document</span></li>\r\n</ul>\n<p><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">6</span></b><b><span lang=\"EN-US\">. Legal and financial set-up of the grants:&nbsp;</span></b><span lang=\"EN-US\">described&nbsp;<span style=\"color: rgb(64, 64, 64);\">in section 10 of the call document</span></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Documents<br />\r\n<br />\r\n<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><b><span lang=\"EN-US\">Call documents:</span></b></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2024/call-fiche_eu4h-2024-pj-02_en.pdf\" target=\"_blank\">Call document </a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/af_eu4h_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">Standard application form ([ToA])</a>&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/detailed-budget-table_eu4h_en.xlsx\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">Detailed budget table ([ToA])</a></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/agr-contr/mga_eu4h_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">EU4Health Programme General MGA v1.1</a></span></p>\r\n<p style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span class=\"MsoHyperlink\" style=\"box-sizing: inherit;\"><span style=\"box-sizing: inherit;\"><a href=\"https://health.ec.europa.eu/publications/2024-eu4health-work-programme_en\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">EU4Health Work Programme 2024</a></span></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.4; background-color: rgb(198, 219, 239); box-sizing: inherit; font-size: 16px; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\">EU4Health&nbsp;</span></a><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; position: relative; cursor: pointer !important;\">Regulation 2021/522</a></span></span><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><br style=\"box-sizing: inherit;\" />\r\n</span><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; box-sizing: inherit; background-color: initial; touch-action: manipulation; cursor: pointer !important;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\">EU Financial Regulation 2018/1046</span></a></p>\n", "supportInfo": "<p><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">For help related to this</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><b style=\"font-family: Arial, sans-serif; font-size: 9pt;\">call</b><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">, please contact:</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><a href=\"mailto:HaDEA-HP-CALLS@ec.europa.eu\" target=\"_blank\" style=\"color: rgb(40, 151, 183); font-family: Arial, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">HaDEA-HP-CALLS@ec.europa.eu</a></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;grantAndTendertype=1;categories=p_submission_eval;programme=null;actions=;keyword=;period=null\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Funding &amp; Tenders Portal FAQ</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Submission of proposals.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">IT Helpdesk</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Online Manual</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Step-by-step online guide through the Portal processes from proposal preparation and submission to reporting on your on-going project. Valid for all 2021-2027 programmes.</span></p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [{"callIdentifier": "EU4H-2024-PJ-02", "status": "Open", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "EU4H-PJG", "criterionDescription": "EU4H Project Grants", "url": "https://ec.europa.eu/research/participants/submission/manage/screen/submission/create-draft/37342?topic=EU4H-2024-PJ-02-1", "startDate": "Jun 18, 2024 12:00:00 AM", "endDate": "Oct 10, 2024 5:00:00 PM", "mgaDescription": "EU4H Action Grant Budget-Based", "mgaCode": "EU4H-AG"}], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"additionalInfo": "<p>&nbsp;<span style=\"text-align: justify; font-size: 10pt; font-family: Verdana, sans-serif;\">On 24 March 2021, the EU4Health Regulation was adopted as part of the EU Multiannual Financial Framework for the 2021-2027 period. The EU4Health Regulation established 'the EU4Health Programme'. This marks an important step towards making available instruments and solutions to support Member States in building stronger, more resilient and accessible health systems.&nbsp;</span><span lang=\"EN-GB\" style=\"text-align: justify; font-size: 10pt; font-family: Verdana, sans-serif;\">&nbsp;</span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">The EU4Health Programme represents an unprecedented level of financial commitment for the EU in health in comparison with previous health programmes. The Programme is EU's response to the current public health emergency that will make a significant contribution to the post-COVID-19 recovery aiming to:</span><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- improve public health in the Union through disease prevention and health promotion, as well as international health initiatives and cooperation;</span><span lang=\"EN-GB\" style=\"font-size:&#10;10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:Verdana;&#10;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- protect people from serious cross-border health threats through prevention, preparedness and response to cross-border health threats; complementing national stockpiling of essential crisis-relevant products; and establishing a reserve of medical, healthcare and support staff;</span><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- improve access to medicinal products, medical devices and crisis-relevant products by encouraging sustainable production and supply chains and innovation in the Union and efficient use of medicinal products;</span><span lang=\"EN-GB\" style=\"font-size:&#10;10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:Verdana;&#10;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"paragraph\" style=\"margin:0cm;text-align:justify;vertical-align:baseline\"><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-bidi-font-family:&#10;Verdana;color:black;mso-fareast-language:EN-GB\">- strengthen the national health systems through improved health data use and re-use, development of digital tools and services, digital transformation of healthcare; enhancing access to healthcare; developing and implementing EU health legislation and evidence-based decision making; and integrated work among Member States' health systems.</span><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;&#10;mso-bidi-font-family:Verdana;color:black;mso-ansi-language:EN-GB;mso-fareast-language:&#10;EN-GB\"><o:p></o:p></span></p>", "latestInfos": [{"approvalDate": "Jun 18, 2024 12:00:01 AM", "lastChangeDate": "Jun 18, 2024 12:00:01 AM", "content": "The submission session is now available for: EU4H-2024-PJ-02-1(EU4H-PJG), EU4H-2024-PJ-02-3(EU4H-PJG), EU4H-2024-PJ-02-2(EU4H-PJG), EU4H-2024-PJ-02-4(EU4H-PJG)"}], "hasForthcomingTopics": false, "hasOpenTopics": true, "allClosedTopics": false}}}